Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Ge Neuro Appoints Anke Post As Chief Medical Officer

PRIVATEApr 06, 2024•about 2 years ago

Position

Chief Medical Officer

Company

GeNeuro

Anke Post
GenevaBiotechnologyHealth CarePharmaceutical

Description

GeNeuro, a leading biopharmaceutical company specializing in treatments for neurological and autoimmune diseases, has announced the appointment of Anke Post as Chief Medical Officer. Anke will bring her extensive experience and expertise to drive the company's clinical development programs forward.

Company Information

Company

GeNeuro

Location

Geneva, Geneva, Switzerland

About

GeNeuro‘s mission is to develop safe and effective treatments against neurological disorders and autoimmune diseases, such as MS, ALS and PASC, by neutralizing pathogenic proteins encoded by HERVs, which represent 8% of human DNA.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for GeNeuro's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.